Beyond Ketamine and Phencyclidine: Analytically Confirmed Use of Multiple Novel Arylcyclohexylamines

References

• Adamowicz, P., and D. Zuba. 2015. Fatal intoxication with methoxetamine. Journal of Forensic Sciences 60 (Suppl 1, January):S264–8. doi:10.1111/1556-4029.12594.
   PubMed Web of Science ®Google Scholar
• Anis, N. A., S. C. Berry, N. R. Burton, and D. Lodge. 1983. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. British Journal of Pharmacology 79:565–75. doi:10.1111/j.1476-5381.1983.tb11031.x.
   PubMed Web of Science ®Google Scholar
• Ayres, T. C., and J. W. Bond. 2012. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the Internet and their impact on public (ill)health: Legal highs or illegal highs? BMJ Open 2 (4, July 31):e000977. doi:10.1136/bmjopen-2012-000977.
   PubMed Web of Science ®Google Scholar
• Bäckberg, M., O. Beck, and A. Helander. 2015. Phencyclidine analog use in Sweden-intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project. Clinical Toxicology (Philadelphia, Pa.) 21 (August):1–9.
   Google Scholar
• Bakota, E., C. Arndt, A. A. Romoser, and S. K. Wilson. 2016. Fatal intoxication involving 3-MeO-PCP: A case report and validated method. Journal of Analytical Toxicology 40 (7):504–10. doi:10.1093/jat/bkw056.
   PubMed Web of Science ®Google Scholar
• Bertol, E., J. Pascali, D. Palumbo, V. Catalani, M. G. Di Milia, A. Fioravanti, F. Mari, and F. Vaiano. 2016. 3-MeO-PCP intoxication in two young men: First in vivo detection in Italy. Forensic Science InternationalS0379-0738(16)30560-6. December 26.
   Web of Science ®Google Scholar
• Bokor, G., and P. D. Anderson. 2014. Ketamine: An update on its abuse. Journal of Pharmacy Practice 27 (6):582–86. doi:10.1177/0897190014525754.
   PubMedGoogle Scholar
• Bush, D. M. 2013. Emergency department visits involving phencyclidine (PCP): The CBHSQ Report. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Ebert, B., S. Mikkelsen, C. Thorkildsen, and F. M. Borgbjerg. 1997. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. European Journal of Pharmacology 333 (1):99–104. doi:10.1016/S0014-2999(97)01116-3.
   PubMed Web of Science ®Google Scholar
• Hill, S. L., S. C. Harbon, J. Coulson, G. A. Cooper, G. Jackson, D. J. Lupton, J. A. Vale, and S. H. Thomas. 2014. Methoxetamine toxicity reported to the national poisons information service: Clinical characteristics and patterns of enquiries (including the period of the introduction of the UK’s first temporary class drug order). Emergency Medicine Journal 31 (1):45–47. doi:10.1136/emermed-2012-202251.
   PubMed Web of Science ®Google Scholar
• Hofer, K. E., B. Grager, D. M. Müller, C. Rauber-Lüthy, H. Kupferschmidt, K. M. Rentsch, and A. Ceschi. 2012. Ketamine-like effects after recreational use of methoxetamine. Annals of Emergency Medicine 60 (1):97–99. doi:10.1016/j.annemergmed.2011.11.018.
   PubMed Web of Science ®Google Scholar
• Menzies, E. L., S. C. Hudson, P. I. Dargan, M. C. Parkin, D. M. Wood, and A. T. Kicman. 2014. Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine. Drug Testing and Analysis 6 (6):506–15. doi:10.1002/dta.1541.
   PubMed Web of Science ®Google Scholar
• Michely, J. A., S. K. Manier, A. T. Caspar, S. D. Brandt, J. Wallach, and H. H. Maurer. 2016. New psychoactive substances 3-methoxyphencyclidine (3-MeO-PCP) and 3-methoxyrolicyclidine (3-MeO-PCPy): Metabolic fate elucidated with rat urine and human liver preparations and their detectability in urine by GC-MS, LC-(high resolution)-MSn, and LC-high resolution-MS/MS. Current Neuropharmacology (October 18).
   Web of Science ®Google Scholar
• Roth, B. L., S. Gibbons, W. Arunotayanun, X. P. Huang, V. Setola, R. Treble, and L. Iversen. 2013. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. Plos One 8 (3):e59334. doi:10.1371/journal.pone.0059334.
   PubMed Web of Science ®Google Scholar
• Shields, J. E., P. I. Dargan, D. M. Wood, M. Puchnarewicz, S. Davies, and W. S. Waring. 2012. Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation. Clinical Toxicology (Philadelphia, Pa.) 50 (5):438–40. doi:10.3109/15563650.2012.683437.
   PubMed Web of Science ®Google Scholar
• United States Code, 2006 Edition, Supplement 4, Title 21: Food and Drugs. 2011. 21 U.S.C. 321: Definitions. July. https://www.gpo.gov/fdsys/granule/USCODE-2010-title21/USCODE-2010-title21-chap9-subchapII-sec321/content-detail.html ( accessed October 31, 2016).
   Google Scholar
• Ward, J., S. Rhyee, J. Plansky, and E. Boyer. 2011. Methoxetamine: A novel ketamine analog and growing health-care concern. Clinical Toxicology (Philadelphia, Pa.) 49 (9):874–75. doi:10.3109/15563650.2011.617310.
   PubMed Web of Science ®Google Scholar
• Wood, D. M., S. Davies, M. Puchnarewicz, A. Johnston, and P. I. Dargan. 2012. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. European Journal of Clinical Pharmacology 68 (5):853–56. doi:10.1007/s00228-011-1199-9.
   PubMed Web of Science ®Google Scholar
• Zanda, M. T., P. Fadda, C. Chiamulera, W. Fratta, and L. Fattore. 2016. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: A review of case reports and preclinical findings. Behavioural Pharmacology 27 (6):489–96. doi:10.1097/FBP.0000000000000241.
   PubMed Web of Science ®Google Scholar
• Zawilska, J. B., and D. Andrzejczak. 2015. Next generation of novel psychoactive substances on the horizon: A complex problem to face. Drug Alcohol Depend 157 (1):1–17. doi:10.1016/j.drugalcdep.2015.09.030.
   PubMed Web of Science ®Google Scholar